Imperial Recognized as 2026 National Best and Brightest Company to Work For! Learn More

Imperial Clinical Research Services Blog
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
Ancillary Clinical Trial Supplies and Equipment Clinical Trial Business Insights

Beyond Logistics: Clinical Trial Supply & Equipment Risk Management

by Kristi Killman November 10, 2026
Ancillary Clinical Trial Supplies and Equipment Clinical Trial Materials Development and Printing

Clinical Trial Startup Challenges: What’s Lurking Around the Corner?

by Dan McDonald October 29, 2026
Clinical Trial Business Insights

The Rhythm of a Year

by Brandon Bissell October 27, 2026
Ancillary Clinical Trial Supplies and Equipment Clinical Trial Business Insights

GCSG European Knowledge Forum: More Than Just Another Conference

by Imogen Cheese October 22, 2026
Ancillary Clinical Trial Supplies and Equipment

Building Flexibility Into Clinical Trial Equipment Planning

by Ted Corrigan October 6, 2026
Clinical Trial Materials Development and Printing Participant Engagement

Just-in-Time Printing for Clinical Trials: A Smarter Approach

by Karlton Gray September 21, 2026
Clinical Trial Materials Development and Printing Participant Engagement Translation of Clinical Trial Materials

3 Steps to Create User-Friendly Participant Materials

by Marta Korgol September 9, 2026
Clinical Trial Business Insights

Rethinking Diversity Through Inclusive Clinical Trial Design

by Vaughn X. Anthony September 2, 2026
Clinical Trial Business Insights Clinical Trial Materials Development and Printing Translation of Clinical Trial Materials

How Version Control in Clinical Trial Materials Reduces Risk

by Heather Ross August 26, 2026
Ancillary Clinical Trial Supplies and Equipment

Why Ancillary Supplies Are Rarely Ancillary in Clinical Trials

by Imogen Cheese August 4, 2026
  • Study & Site Print Materials

  • Ancillary Trial Supplies

  • Translation Services

  • Trial Patient Engagement

    Clinical Trial Materials Development and Printing

    Developing Regulatory-Compliant Patient Materials

    by Felicia Fuller January 17, 2014
    written by Felicia Fuller

    Every study needs a voice — messaging that communicates the trial sponsor’s core objectives. Patient recruitment professionals provide this through compelling content and artful designs that resonate with target audiences and inspire study participation. But beyond being current and compelling, study collateral must also be regulatory-compliant.

    Though regulations vary slightly per country, generally speaking, patient-facing content that promotes an investigational product must make no expressed or implied claims of efficacy according to the Code of Federal Regulations Title 21, Sec. 312.7, Promotion and charging for investigational drugs.

    That sounds simple enough, but the term “implied’ is subjective and open to interpretation.So what is one to do? Imperial adheres to the following guidelines in developing patient-facing materials for global audiences.

    Required Patient Content

    • A statement indicating a research study is being conducted
    • The disease or condition being studied
    • Key eligibility criteria in layman’s language, for example, liver instead of hepatic, heart instead of coronary, etc.
    • Contact information so potential participants can request more information

    Additional Permitted Patient Content

    • The purpose of the research
    • The location of the research
    • The company sponsoring the research (if the client agrees to include this)
    • Whether the participant will be compensated for participation
    • Balanced statements of potential benefits and risks of study participation

    Prohibited Content

    • Claims of safety or effectiveness
    • References to “free medical treatment” when the intent is only to say participants will not have to pay for taking part in the study
    • Undue emphasis on patient reimbursement by giving the dollar amount or through special text treatment, such as boldface, italics or underlining
    • Claims that the investigational product is approved by the FDA or other regulatory body for use in patients with the target disease or condition
    • Use of the term “new” unless qualified as a “new investigational medication”
    • Use of the term “treatment” in the context of the investigational medication
    • The compound name, unless it is currently approved and marketed for another indication and the sponsor approves of its use in the materials
    • Overly promotional terms such as groundbreaking, exciting, important, unprecedented, etc.

    Graphic Requirements

    To avoid subliminal implications of efficacy, avoid depictions of smiling faces or people who appear markedly healthier than the target population. For example, an advertisement aimed at patients with mobility issues should not feature images of people performing physically demanding feats, such as mountain-climbing.

    When in doubt, err on the side of caution and consult your patient recruitment provider or regulatory agency. For further information, visitwww.fda.gov. 

    January 17, 2014 0 comments
    0 FacebookTwitterLinkedinEmail
  • Participant Engagement

    New Trends in Web Marketing

    by Mark Gerlach January 10, 2014
    by Mark Gerlach January 10, 2014

    What is your marketing message? Can you answer this question in one clear, concise sentence? In today’s digital world, individuals don’t have time to sift through a convoluted marketing message. You may only have an instant to grab someone’s attention and with a plethora of …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business InsightsParticipant Engagement

    An Inside Look at Privacy Laws

    by Melynda Geurts January 2, 2014
    by Melynda Geurts January 2, 2014

    We talk a lot about privacy and how we can and cannot reach the public about clinical trials. What is privacy? By definition, privacy is “the quality or state of being apart from company or observation; seclusion or freedom from unauthorized intrusion.” So what does …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business Insights

    Avoiding Common Pitfalls in Multinational Clinical Trials

    by Dan McDonald December 17, 2013
    by Dan McDonald December 17, 2013

    By Dan McDonald Multinational clinical trials are challenging. The international industry is rapidly maturing, but horror stories are still common: “Our study drug is melting in a hot locker in customs, and I can’t get hold of anyone.” “Sure, that country enrolled like gangbusters, but …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business Insights

    Looking Back to Move Forward

    by Steve Swanson December 17, 2013
    by Steve Swanson December 17, 2013

    As 2013 rapidly comes to a close, we reflect back, analyze and establish forward 2014 goals for our organization. Reflecting back provides us with more awareness of trends affecting all of us in the life-sciences industry. Consolidation and outsourcing have continued, as has increased awareness …

    0 FacebookTwitterLinkedinEmail
Load More Posts

Signup for our Blog Subscription

Signup for our Blog Subscription

Keep in touch

Twitter Linkedin Youtube Email Rss

Popular Posts

  • 1

    Clinical Research Phases and the Path to Drug Approval

    August 8, 2023
  • 2

    See Do Get

    August 12, 2014
  • 3

    Google Translate: The Unwitting Confidentiality Flaw

    April 15, 2020
  • 4

    25 Reasons People Aren’t Enrolling in Your Clinical Trial

    October 29, 2015
  • 5

    The Upcoming FDA Clinical Trial Diversity Mandate: What You Need to Know

    May 14, 2025

Categories

  • Ancillary Clinical Trial Supplies and Equipment (44)
  • Clinical Trial Business Insights (198)
  • Clinical Trial Materials Development and Printing (55)
  • Participant Engagement (113)
  • Translation of Clinical Trial Materials (21)
Imperial Clinical Research Services Blog

Imperial is a global leader in clinical trial solutions and support, specializing in study and site print materials, ancillary trial supplies and equipment, clinical trial translation management, and clinical trial patient engagement.

Imperial CRS Corporate Headquarters
3100 Walkent Drive NW
Grand Rapids, MI 49544

Contact

connect@imperialcrs.com

800.777.2591

020 3887 3437

Employment

Social

We Run on EOS - Entrepreneurial Operating SystemEcovadis Sustainability Rating January 2024West Michigan's Best and Brightest Companies to Work For Winner 2025The Best and Brightest Companies to Work For Logo
© Imperial CRS, LLC | Privacy Policy
Signup for our Blog Subscription

Subscribetoourblogandgetthelatestupdates,insights,andindustrytrendsdeliveredstraighttoyourinbox.Stayinformedandnevermissapost.

 

 


Imperial Clinical Research Services Blog
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace